An Adult Spasticity Registry of OnabotulinumtoxinA Treatment
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms ASPIRE
- Sponsors Allergan
- 11 Oct 2017 Status changed from active, no longer recruiting to completed.
- 20 Jul 2017 Planned End Date changed from 1 Sep 2017 to 11 Oct 2017.
- 20 Jul 2017 Planned primary completion date changed from 1 Sep 2017 to 11 Oct 2017.